Melanin-Adjusted Blood Oxygen Sensor in ICU Patients
Official title: Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings: Improving the Accuracy in Critical Conditions for Patients of Color
Run by University of North Carolina, Chapel Hill · NCT07799454 · Data updated 2026-11-12
This study tests a new pulse oximeter that adjusts for skin pigment to see if it gives accurate oxygen readings in ICU patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of North Carolina, Chapel Hill Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | January 6, 2026 |
| Main results expected | December 15, 2026 |
| Study ends | December 15, 2026 |
| Registry record updated | September 2, 2026 |
| Trial ID | NCT07799454 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 to 85 admitted to UNC Medical ICU or Cardiovascular and Thoracic ICU who require at least two arterial blood gas measurements within 24 hours.
✕Probably not a fit
Patients with active skin disorders, tattoos on sensor sites, or conditions affecting melanin outside the included spectrum may not benefit from the device.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study evaluates the accuracy of a novel pulse oximeter, MABOS, across adults with varying skin tones who require frequent arterial blood gas measurements in intensive care settings. Participants will have skin tone measured with a spectrophotometer and will wear the MABOS device on one finger of each hand, plus a variant on an additional finger and wrist. Data from all devices will be collected continuously for up to 24 hours or until four arterial blood gas tests are obtained. Enrollment targets up to 120 adults admitted to UNC Hospitals’ ICUs. English proficiency is required for participants or their legally authorized representatives.
Why it matters
Potential benefit: If successful, patients may receive more accurate oxygen readings across skin tones, potentially improving critical-care decisions.
How similar studies have gone: Prior work with alternative pulse oximeter technologies has shown variable accuracy across skin tones; this approach aims to address that gap, with mixed prior results in similar devices.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ranges from 18 to 85 years. * Individuals admitted to one of UNC Hospital's intensive care units (Medical Intensive Care Unit or Cardiovascular and Thoracic Intensive Care Unit). * Individuals with a medical condition necessitating a minimum of two arterial blood gas measurements within a 24-hour period. * Participant, or Legally Authorized Representative (LAR) must be able to read, write, and speak English fluently. Exclusion Criteria: * History of active (clinically significant) skin disorders that make skin vulnerable to contact with conventional electronic devices. * History of allergic response to silicones, adhesives (such as 3M Tegaderm), or acetone. * Broken, damaged or irritated skin or rashes near the sensor application sites. * Presence of tattoos on the fingers, hands, or forearms. * History of a genetic condition or skin disorder that variably impacts the amount of melanin pigmentation (e.g., Vitiligo). * Pregnant or lactating individuals * Individuals given methylene blue within the last 24 hours or Hydroxocobalamin within the last 2 weeks. * Individuals experiencing carbon monoxide poisoning. * History of conditions that may affect ABG readings (e.g., lipemic specimens). * History of hematological conditions affecting red blood cell morphology (e.g., sickle cell disease) * Patients on Venoarterial extracorporeal membrane oxygenation (VA-ECMO), durable left ventricular assist device (LVAD), or Impella.
Where it's running
-
University of North Carolina at Chapel Hill Hospitals
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Wubin Bai, Ph.D. — University of North Carolina, Chapel Hill
- Study coordinator: Arjun Putcha, M.S.
- Email: arjun22@live.unc.edu
- Phone: 704-954-4398
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HFNO vs. face mask for cerebral oxygenation during procedural sedation
This randomized trial tests whether high-flow nasal oxygen helps maintain brain oxygenation better than a standard face mask during procedures done with sedation in adults.
-
HFNC vs Microstream nasal cannula during ERCP
This study compares high-flow nasal oxygen with the Microstream Advance nasal cannula to see which one better keeps patients’ oxygen levels stable during ERCP procedures done under deep sedation.
-
Extra oxygen during the 6-minute walk for people with chronic respiratory failure or exercise-related low oxygen
This trial will test whether giving extra oxygen during a 6-minute walk helps people with chronic respiratory failure or exertional low oxygen from COPD or interstitial lung disease walk farther, breathe better, and feel easier during the test.
-
Safety and performance of the INBENTUS VERSATILE ventilator in adults on invasive mechanical ventilation
This trial will test whether the INBENTUS VERSATILE ventilator is safe and performs well in adults who need assisted or controlled invasive mechanical ventilation and short-term weaning.
-
PIMUN to reduce low-oxygen episodes in preterm infants
We will test whether PIMUN, a soft garment that gives gentle pulsatile dorsal stimulation, can reduce low-oxygen (SpO2 <90%) episodes in preterm infants born at 24–34 weeks who have apnea of prematurity.
-
COMBO airway plus high-flow nasal oxygen during sedated gastrointestinal endoscopy for morbidly obese adults
This test will try combining the COMBO Endoscopy oropharyngeal airway with high-flow nasal oxygen to see if it reduces low-oxygen episodes during sedated gastrointestinal endoscopy in adults with BMI 35 or higher.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.